drugset / Trial / NCT03612401

Treatment of Spinal Cord Injury Patients for Neurogenic Bladder: Anticholinergic Agent vs. Mirabegron

NCT03612401

NaSingle-groupOpen-labelTreatment

Summary

We propose to test the hypothesis that cognition will improve with substitution of mirabegron for the anticholinergic agent (AC) in elderly persons with spinal cord injury (SCI) who require neurogenic bladder (NGB) treatment.

Timeline

Start
2018-12-05
Primary completion
2020-03-23
Completion
2021-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirabegron Other / unclassified

Indications